Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain
- Moreno, S.
- Rivero, A.
- Ventayol, P.
- Falcó, V.
- Torralba, M.
- Schroeder, M.
- Neches, V.
- Vallejo-Aparicio, L.A.
- Mackenzie, I.
- Turner, M.
- Harrison, C.
ISSN: 2193-6382, 2193-8229
Argitalpen urtea: 2023
Alea: 12
Zenbakia: 8
Orrialdeak: 2039-2055
Mota: Artikulua